$OSK
OSHKOSH CORP

2023 Q2 Form 10-Q Financial Statement

#000095017023015169 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $2.413B $2.268B $1.946B
YoY Change 16.8% 16.57% 3.0%
Cost Of Revenue $1.989B $1.934B $1.744B
YoY Change 8.91% 10.89% 10.83%
Gross Profit $424.5M $333.8M $201.3M
YoY Change 76.8% 65.82% -36.12%
Gross Profit Margin 17.59% 14.72% 10.35%
Selling, General & Admin $185.4M $199.1M $169.2M
YoY Change 10.42% 17.67% -2.53%
% of Gross Profit 43.67% 59.65% 84.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.80M $30.50M $20.70M
YoY Change 58.69% 47.34% 2.48%
% of Gross Profit 7.96% 9.14% 10.28%
Operating Expenses $189.6M $203.0M $172.0M
YoY Change 11.07% 18.02% -2.22%
Operating Profit $234.9M $130.8M $29.30M
YoY Change 238.47% 346.42% -79.19%
Interest Expense -$8.100M -$7.200M -$11.60M
YoY Change -31.93% -37.93% 3.57%
% of Operating Profit -3.45% -5.5% -39.59%
Other Income/Expense, Net $4.800M $5.800M $1.100M
YoY Change -131.79% 427.27% -64.52%
Pretax Income $231.6M $129.4M $18.80M
YoY Change 446.23% 588.3% -85.83%
Income Tax $56.30M $34.20M $20.20M
% Of Pretax Income 24.31% 26.43% 107.45%
Net Earnings $175.0M $88.50M -$2.100M
YoY Change 550.56% -4314.29% -102.11%
Net Earnings / Revenue 7.25% 3.9% -0.11%
Basic Earnings Per Share
Diluted Earnings Per Share $2.67 $1.34 -$31.63K
COMMON SHARES
Basic Shares Outstanding 65.31M 65.43M 66.39M
Diluted Shares Outstanding 65.66M 65.83M 66.39M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $355.5M $538.7M $944.5M
YoY Change -10.54% -42.96% -13.6%
Cash & Equivalents $355.5M $538.7M $944.5M
Short-Term Investments
Other Short-Term Assets $74.70M $87.10M $64.50M
YoY Change 4.04% 35.04% -57.9%
Inventory $1.900B $1.906B $1.528B
Prepaid Expenses
Receivables $2.041B $1.866B $1.502B
Other Receivables $15.70M $15.80M $255.2M
Total Short-Term Assets $4.387B $4.414B $4.294B
YoY Change 8.23% 2.79% 7.85%
LONG-TERM ASSETS
Property, Plant & Equipment $890.5M $871.5M $603.7M
YoY Change 32.02% 44.36% 7.57%
Goodwill $1.152B $1.129B $1.045B
YoY Change 10.44% 8.07% -3.83%
Intangibles $533.4M $536.1M $464.9M
YoY Change 14.56% 15.32% 3.93%
Long-Term Investments
YoY Change
Other Assets $1.059B $326.9M $436.3M
YoY Change 110.97% -25.07% 62.98%
Total Long-Term Assets $3.658B $3.503B $2.681B
YoY Change 30.32% 30.67% 13.46%
TOTAL ASSETS
Total Short-Term Assets $4.387B $4.414B $4.294B
Total Long-Term Assets $3.658B $3.503B $2.681B
Total Assets $8.044B $7.916B $6.975B
YoY Change 17.27% 13.5% 9.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.068B $1.091B $982.3M
YoY Change 5.5% 11.09% 48.32%
Accrued Expenses $165.0M $146.9M $138.5M
YoY Change 12.4% 6.06% -25.38%
Deferred Revenue $628.7M $688.9M $755.6M
YoY Change -16.96% -8.83% 7.03%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $2.100M
YoY Change -100.0%
Total Short-Term Liabilities $2.418B $2.459B $2.446B
YoY Change 3.39% 0.5% 28.58%
LONG-TERM LIABILITIES
Long-Term Debt $597.3M $595.2M $594.4M
YoY Change 0.45% 0.13% -27.36%
Other Long-Term Liabilities $1.614B $504.8M $510.6M
YoY Change 223.23% -1.14% -15.58%
Total Long-Term Liabilities $2.211B $1.100B $1.105B
YoY Change 102.14% -0.45% -22.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.418B $2.459B $2.446B
Total Long-Term Liabilities $2.211B $1.100B $1.105B
Total Liabilities $4.648B $3.559B $3.551B
YoY Change 35.39% 0.21% 6.79%
SHAREHOLDERS EQUITY
Retained Earnings $3.525B $3.377B $3.084B
YoY Change 14.21% 9.49% 7.42%
Common Stock $816.8M $808.7M $798.9M
YoY Change 1.69% 1.23% -0.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $861.7M $854.9M $781.0M
YoY Change 1.42% 9.46% 66.92%
Treasury Stock Shares $9.723M $9.001M
Shareholders Equity $3.397B $3.247B $2.968B
YoY Change
Total Liabilities & Shareholders Equity $8.044B $7.916B $6.975B
YoY Change 17.27% 13.5% 9.94%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $175.0M $88.50M -$2.100M
YoY Change 550.56% -4314.29% -102.11%
Depreciation, Depletion And Amortization $33.80M $30.50M $20.70M
YoY Change 58.69% 47.34% 2.48%
Cash From Operating Activities -$126.4M $79.80M $328.9M
YoY Change -64.07% -75.74% 0.64%
INVESTING ACTIVITIES
Capital Expenditures $17.10M $111.5M -$28.00M
YoY Change -119.68% -498.21% 48.15%
Acquisitions $187.9M
YoY Change
Other Investing Activities -$1.200M $1.200M -$12.10M
YoY Change -90.16% -109.92% 236.11%
Cash From Investing Activities -$18.30M -$277.1M -$40.10M
YoY Change -81.53% 591.02% -67.21%
FINANCING ACTIVITIES
Cash Dividend Paid $26.80M $24.50M
YoY Change 9.39% 7.93%
Common Stock Issuance & Retirement, Net $85.40M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -38.00M -71.10M -337.9M
YoY Change -56.57% -78.96% 5828.07%
NET CHANGE
Cash From Operating Activities -126.4M 79.80M 328.9M
Cash From Investing Activities -18.30M -277.1M -40.10M
Cash From Financing Activities -38.00M -71.10M -337.9M
Net Change In Cash -182.7M -267.2M -51.20M
YoY Change -66.07% 421.88% -126.31%
FREE CASH FLOW
Cash From Operating Activities -$126.4M $79.80M $328.9M
Capital Expenditures $17.10M $111.5M -$28.00M
Free Cash Flow -$143.5M -$31.70M $356.9M
YoY Change -45.83% -108.88% 3.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-31371
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Oshkosh Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WI
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-0520270
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1917 Four Wheel Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Oshkosh
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
54902
CY2023Q1 dei City Area Code
CityAreaCode
920
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
502-3400
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
OSK
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65313605
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000775158
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2268100000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1945700000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1934300000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1741900000
CY2023Q1 us-gaap Gross Profit
GrossProfit
333800000
CY2022Q1 us-gaap Gross Profit
GrossProfit
203800000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
199100000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169200000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
203000000.0
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
172000000.0
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
130800000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31800000
CY2023Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
13400000
CY2022Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
12600000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
6200000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000.0
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5800000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1100000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
129400000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21300000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34200000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20800000
CY2023Q1 osk Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
95200000
CY2022Q1 osk Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments
500000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6700000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-700000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
88500000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-200000
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.35
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.34
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.41
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
CY2023Q1 us-gaap Profit Loss
ProfitLoss
88500000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-200000
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
400000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-400000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
11400000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6500000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
2000000.0
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-800000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000000.0
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5300000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
97500000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5500000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
538700000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
805900000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1311700000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1162000000.0
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
554400000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
586300000
CY2023Q1 us-gaap Inventory Net
InventoryNet
1905900000
CY2022Q4 us-gaap Inventory Net
InventoryNet
1865600000
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
15800000
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
21600000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
87100000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
90700000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4413600000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4532100000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
871500000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
826200000
CY2023Q1 us-gaap Goodwill
Goodwill
1129200000
CY2022Q4 us-gaap Goodwill
Goodwill
1042000000.0
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
536100000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
457000000.0
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
153200000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
134800000
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
485900000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
415800000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
326900000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
321100000
CY2023Q1 us-gaap Assets
Assets
7916400000
CY2022Q4 us-gaap Assets
Assets
7729000000.0
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2100000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9700000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1091200000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1129000000.0
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
688900000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
696700000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
146900000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
119500000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
150500000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
100300000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
379000000.0
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
373400000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2458600000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2428600000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
595200000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
595000000.0
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1110600000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1020500000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
504800000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
499200000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75101465
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75101465
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
700000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
700000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
808000000.0
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
806000000.0
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3376700000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3315000000.0
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-83300000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-92300000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
9722694
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
9629317
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
854900000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
843700000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3247200000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3185700000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7916400000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7729000000.0
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3185700000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
88500000
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
100000
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
400000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
11400000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-2000000.0
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.41
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
26800000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
15200000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2500000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6800000
CY2023Q1 osk Adjustments Related To Tax Withholding Shares Tendered For Taxes On Share Based Compensation
AdjustmentsRelatedToTaxWithholdingSharesTenderedForTaxesOnShareBasedCompensation
3400000
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-100000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3247200000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3204300000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-200000
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-100000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-400000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6500000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
800000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
24500000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
85000000.0
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1900000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6800000
CY2022Q1 osk Adjustments Related To Tax Withholding Shares Tendered For Taxes On Share Based Compensation
AdjustmentsRelatedToTaxWithholdingSharesTenderedForTaxesOnShareBasedCompensation
400000
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-200000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3097800000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
88500000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-200000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30500000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26400000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6800000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6800000
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-11000000.0
CY2023Q1 osk Deferred Income Tax Expense Benefit Continuing And Discontinued Operations
DeferredIncomeTaxExpenseBenefitContinuingAndDiscontinuedOperations
-26300000
CY2022Q1 osk Deferred Income Tax Expense Benefit Continuing And Discontinued Operations
DeferredIncomeTaxExpenseBenefitContinuingAndDiscontinuedOperations
1600000
CY2023Q1 osk Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
100000
CY2022Q1 osk Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
1000000.0
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
800000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1500000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6900000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
600000
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
36700000
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-297400000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
79800000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
328900000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
111500000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26100000
CY2023Q1 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
1200000
CY2022Q1 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
1900000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
187900000
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
23100000
CY2023Q1 osk Proceeds From Sale Of Equipment Held For Rental
ProceedsFromSaleOfEquipmentHeldForRental
1600000
CY2022Q1 osk Proceeds From Sale Of Equipment Held For Rental
ProceedsFromSaleOfEquipmentHeldForRental
3200000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1200000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
15300000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-277100000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40100000
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
25000000.0
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
225000000.0
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15200000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
85000000.0
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
26800000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
24500000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4100000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3400000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71100000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-337900000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1200000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2100000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-267200000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51200000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
805900000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
995700000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
538700000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
944500000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
8400000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
10100000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2400000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5300000
CY2023Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
900000
CY2022Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
300000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
12400000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
11500000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7800000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2800000
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
76100000
CY2021Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
66900000
CY2023Q1 us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
9000000.0
CY2023Q1 osk Schedule Of Changes Within Defense Segment Due To Contract Adjustments Table Textblock
ScheduleOfChangesWithinDefenseSegmentDueToContractAdjustmentsTableTextblock
<p style="text-indent:3.333%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Contract adjustments impacted the Company’s results as follows (in millions, except per share amounts):</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.377%;"/> <td style="width:1.629%;"/> <td style="width:1.0%;"/> <td style="width:12.683%;"/> <td style="width:1.0%;"/> <td style="width:1.629%;"/> <td style="width:1.0%;"/> <td style="width:12.683%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">2023</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Net sales</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">6.5</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">7.9</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Operating income</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">14.4</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">10.6</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Net income</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">11.0</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">8.1</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">Diluted earnings per share</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">0.17</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">(</span><span style="font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">0.12</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.5pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">)</span></p></td> </tr> </table>
CY2023Q1 osk Increase Decrease In Net Sales Due To Margin Rate Adjustments
IncreaseDecreaseInNetSalesDueToMarginRateAdjustments
-6500000
CY2022Q1 osk Increase Decrease In Net Sales Due To Margin Rate Adjustments
IncreaseDecreaseInNetSalesDueToMarginRateAdjustments
-7900000
CY2023Q1 osk Increase Decrease In Operating Income Due To Margin Rate Adjustments
IncreaseDecreaseInOperatingIncomeDueToMarginRateAdjustments
-14400000
CY2022Q1 osk Increase Decrease In Operating Income Due To Margin Rate Adjustments
IncreaseDecreaseInOperatingIncomeDueToMarginRateAdjustments
-10600000
CY2023Q1 osk Increase Decrease In Net Income Due To Margin Rate Adjustments
IncreaseDecreaseInNetIncomeDueToMarginRateAdjustments
-11000000.0
CY2022Q1 osk Increase Decrease In Net Income Due To Margin Rate Adjustments
IncreaseDecreaseInNetIncomeDueToMarginRateAdjustments
-8100000
CY2023Q1 osk Increase Decrease In Earnings Per Share Due To Margin Rate Adjustments In Dollar Per Share
IncreaseDecreaseInEarningsPerShareDueToMarginRateAdjustmentsInDollarPerShare
-0.17
CY2022Q1 osk Increase Decrease In Earnings Per Share Due To Margin Rate Adjustments In Dollar Per Share
IncreaseDecreaseInEarningsPerShareDueToMarginRateAdjustmentsInDollarPerShare
-0.12
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2268100000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1945700000
CY2023Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
688900000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
696700000
CY2023Q1 osk Contract With Customer Other Current Liability
ContractWithCustomerOtherCurrentLiability
74700000
CY2022Q4 osk Contract With Customer Other Current Liability
ContractWithCustomerOtherCurrentLiability
77400000
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1110600000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1020500000
CY2023Q1 osk Contract With Customer Other Liability Noncurrent
ContractWithCustomerOtherLiabilityNoncurrent
65500000
CY2022Q4 osk Contract With Customer Other Liability Noncurrent
ContractWithCustomerOtherLiabilityNoncurrent
66800000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1939700000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1861400000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
189200000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
118300000
CY2022Q1 us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
7200000
CY2023Q1 osk Product Warranty Amortization
ProductWarrantyAmortization
-6500000
CY2022Q1 osk Product Warranty Amortization
ProductWarrantyAmortization
-4800000
CY2023Q1 us-gaap Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
ExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
100000
CY2022Q1 us-gaap Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
ExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-200000
CY2023Q1 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
78700000
CY2022Q1 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
69100000
CY2023Q1 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
26400000
CY2022Q4 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
26800000
CY2023Q1 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
52300000
CY2022Q4 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
49300000
CY2023Q1 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
78700000
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
76100000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9830000000
CY2023Q1 osk Transaction Price Allocated To Performance Obligations To Be Satisfied During Current Fiscal Year
TransactionPriceAllocatedToPerformanceObligationsToBeSatisfiedDuringCurrentFiscalYear
2080000000.00
CY2023Q1 osk Transaction Price Allocate To Performance Obligations Expected To Be Satisfied During The Subsequent Fiscal Year
TransactionPriceAllocateToPerformanceObligationsExpectedToBeSatisfiedDuringTheSubsequentFiscalYear
2760000000
CY2023Q1 osk Transaction Price Allocated To Performance Obligations Expected To Be Satisfied Beyond Current Fiscal Year
TransactionPriceAllocatedToPerformanceObligationsExpectedToBeSatisfiedBeyondCurrentFiscalYear
4990000000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2840963
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6800000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5800000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6500000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5500000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34200000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.264
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20800000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.977
CY2023Q1 osk Income Tax Expense Benefit Tax Credit Discrete Items
IncomeTaxExpenseBenefitTaxCreditDiscreteItems
3400000
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1700000
CY2022Q1 osk Income Tax Expense Benefit Tax Credit Discrete Items
IncomeTaxExpenseBenefitTaxCreditDiscreteItems
15400000
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
18100000
CY2022Q1 osk Benefit For Release Of Foreign Tax Credit Valuation Allowance
BenefitForReleaseOfForeignTaxCreditValuationAllowance
3800000
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
93800000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
98800000
CY2023Q1 osk Unrecognized Tax Benefits That Would Impact Net Income
UnrecognizedTaxBenefitsThatWouldImpactNetIncome
54300000
CY2023Q1 osk Unrecognized Tax Benefits Income Tax Penalties And Interest Expense Income
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseIncome
900000
CY2022Q1 osk Unrecognized Tax Benefits Income Tax Penalties And Interest Expense Income
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseIncome
600000
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
5700000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65440014
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66394041
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
390971
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65830985
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66394041
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
522003
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7100000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5900000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
600000000.0
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5000000.0
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
595000000.0
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
9700000
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
10800000
CY2023Q1 osk Debt Instrument Leverage Ratio
DebtInstrumentLeverageRatio
0.0375
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
58800000
CY2023Q1 us-gaap Government Contract Receivable
GovernmentContractReceivable
124700000
CY2022Q4 us-gaap Government Contract Receivable
GovernmentContractReceivable
135300000
CY2023Q1 osk Other Trade Receivables
OtherTradeReceivables
1135800000
CY2022Q4 osk Other Trade Receivables
OtherTradeReceivables
979500000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
8300000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
7300000
CY2023Q1 osk Notes Receivable
NotesReceivable
7600000
CY2023Q1 us-gaap Other Receivables
OtherReceivables
58000000.0
CY2022Q4 us-gaap Other Receivables
OtherReceivables
53300000
CY2023Q1 osk Receivables Gross
ReceivablesGross
1334400000
CY2022Q4 osk Receivables Gross
ReceivablesGross
1175400000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7100000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6700000
CY2023Q1 osk Receivables Net
ReceivablesNet
1327300000
CY2022Q4 osk Receivables Net
ReceivablesNet
1168700000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1311700000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1162000000.0
CY2023Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
15600000
CY2022Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
6700000
CY2023Q1 osk Receivables Net
ReceivablesNet
1327300000
CY2022Q4 osk Receivables Net
ReceivablesNet
1168700000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6700000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4200000
CY2023Q1 osk Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
400000
CY2022Q1 osk Provision For Doubtful Accounts Net Of Recoveries
ProvisionForDoubtfulAccountsNetOfRecoveries
1700000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1114400000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1140600000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
403400000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
383100000
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
388100000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
341900000
CY2023Q1 us-gaap Inventory Net
InventoryNet
1905900000
CY2022Q4 us-gaap Inventory Net
InventoryNet
1865600000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1873600000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1804400000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1002100000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
978200000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
871500000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
826200000
CY2023Q1 us-gaap Depreciation
Depreciation
23300000
CY2022Q1 us-gaap Depreciation
Depreciation
20700000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12600000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
10100000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
600000000.0
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4800000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
595200000
CY2023Q1 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
2100000
CY2022Q4 us-gaap Goodwill
Goodwill
1042000000.0
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1700000
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
85500000
CY2023Q1 us-gaap Goodwill
Goodwill
1129200000
CY2023Q1 us-gaap Goodwill Gross
GoodwillGross
2230700000
CY2023Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1101500000
CY2023Q1 us-gaap Goodwill
Goodwill
1129200000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
2145800000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1103800000
CY2022Q4 us-gaap Goodwill
Goodwill
1042000000.0
CY2023Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P14Y
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
839000000.0
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
715800000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123200000
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
412900000
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
412900000
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1251900000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
715800000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
536100000
CY2022 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P14Y2M12D
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
790400000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
720800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
69600000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
387400000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
387400000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1177800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
720800000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
457000000.0
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
9700000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12700000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12600000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
12600000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
65700000
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
14900000
CY2022Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
11100000
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
12400000
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
13600000
CY2023Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-700000
CY2022Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-1600000
CY2023Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-500000
CY2023Q1 us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
200000
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
60300000
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
61600000
CY2019Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
4109419
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
7890581
CY2022Q2 osk Increased Number Of Shares Of Common Stock Authorized For Buyback
IncreasedNumberOfSharesOfCommonStockAuthorizedForBuyback
12000000
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
173169
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
15200000
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
751309
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
85000000.0
CY2023Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
11377508
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
3100000
CY2023Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
9600000
CY2023Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
900000
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
3800000
CY2022Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
12700000
CY2022Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1600000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2268100000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1945700000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
130800000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31800000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7200000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11600000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5800000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1100000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
129400000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21300000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2268100000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1945700000

Files In Submission

Name View Source Status
0000950170-23-015169-index-headers.html Edgar Link pending
0000950170-23-015169-index.html Edgar Link pending
0000950170-23-015169.txt Edgar Link pending
0000950170-23-015169-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
osk-20230331.htm Edgar Link pending
osk-20230331.xsd Edgar Link pending
osk-ex31_1.htm Edgar Link pending
osk-ex31_2.htm Edgar Link pending
osk-ex32_1.htm Edgar Link pending
osk-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
osk-20230331_cal.xml Edgar Link unprocessable
osk-20230331_lab.xml Edgar Link unprocessable
osk-20230331_pre.xml Edgar Link unprocessable
osk-20230331_htm.xml Edgar Link completed
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
osk-20230331_def.xml Edgar Link unprocessable